CURRENT ISSUE

Genetic Engineering " Biotechnology News - Current Issue

(view larger image)

SUBSCRIBE

AD LINK

Visit GEN on Twitter!

Welcome to BLOGbiotech

Nanotechnologists Create Artificial Pore

posted on 5 November 2009 4:28PM EST

View / Add Comments(0)

Using an RNA-powered nanomotor, University of Cincinnati (UC) biomedical engineering scientists successfully developed an artificial pore able to transmit nanoscale material through a membrane.

In a study led by Dr. Peixuan Guo, members of the UC team inserted the modified core of a nanomotor into a lipid membrane. The resulting channel enabled them to move both single- and double-stranded DNA through the membrane.

During this week's podcast Dr. Guo talks about the creation of the RNA nanomotor and provides additional ...more.


BIO-Europe 2009 Day 3

by Susan Aldridge

posted on 4 November 2009 6:29PM EST

View / Add Comments(0)

Drug delivery seems to be a major theme here this year. I hope Light Sciences Oncology CEO Llew Keltner will forgive my stretching the concept to include the technology his company has developed which is promising to make light-activated therapy for cancer a clinical reality. The traditional approach to light-activated therapy uses a laser to deliver the light, which is not really practical in the clinic. The LSO product, Aptocine ™ is a combination of an LED array delivered to a tumor via biopsy and a non-toxic water soluble photosensitive compound, talaporfin sodium. Phase III results in ...more.


BIO-Europe 2009 Day 2

by Susan Aldridge

posted on 4 November 2009 7:11AM EST

View / Add Comments(0)

BIO-Europe 2009 Day 2



An interesting deal announced here is between Malaysian drug delivery company SIOGEN Biotech and Grampian Bioconsultants Ltd, a recent spinout from Aberdeen University with a focus on immunotherapy and cancer. SIOGEN was voted the most innovative biotech startup in the Asia Pacific region for 2009. The company’s Designer Siosomes ® are liposome-like nanoparticles based upon silicon. Grampian will couple antibodies onto the surface of the Siosomes for more accurate delivery into tissues like lung and heart. SIOGEN Exec Chairman Zoser Salama thinks Siosomes ...more.


BIO-Europe 2009

by Susan Aldridge

posted on 3 November 2009 7:47AM EST

View / Add Comments(1)

BIO-Europe 2009 Day 1





Greetings from snowy Vienna, where I am representing GEN at BIO-Europe 2009. There’s lots to discover – as there are over 1,400 companies here (many of them old friends of GEN, but probably more that are completely unknown to me!). My first discovery is Mercordia, a Swedish company developing a diagnostic test for oxidised LDL. Sounds like this could be a good marker to add to a lipid panel – the clinical rationale seems strong. Next, I’m told (by Belgian consultant Thérèse Delatte) that Pharmadiagnostics is a company to watch. Why? Because ...more.


What Will YOU Do?

by Gail Dutton

posted on 30 October 2009 6:10PM EST

View / Add Comments(0)

Gail Dutton



I’ve debated about this post for a long time now, and not wanting to believe that what I am seeing could possibly be happening. Surely some critical piece of information was missing that could prove me wrong. Well, it probably is missing, but I’ve come to the conclusion that entrepreneurs in the U.S. should be afraid, very afraid. And, lest the point be overlooked, biotech companies ARE entrepreneurial.



Point 1. The U.S. government took over two of our three car companies, tossing out contract law and shareholder rights. Last autumn, the government bailed ...more.


pages:    1 2 3 4 5 6 7 8 9 10 11 >>


NOTICE: As such, the comments on this blog were, are, and will always be solely the opinions of the individuals leaving them. In no way does Genetic Engineering & Biotechnology News, GEN Publishing, Inc., or Mary Ann Liebert ,Inc. endorse, condone, agree with, sponsor, etc. these comments.

CAREER CENTER

Visit the GEN Career Center

for the latest biotech employment opportunities.
Start your search HERE!

visit the Career Center

WEBINARS


view all webinars

GEN and Scintellix bring you the Cryptogram Challenge: ELISA REDUX!

PODCASTS

INTERVIEW: NANOTECHNOLOGISTS CREATE ARTIFICIAL PORE - Interview with Peixuan Guo, Ph.D., Director of the NIH Nanomedicine Development Center at the University of Cincinnati, Endowed Chair, and Professor of Biomedical Engineering ...MORE

MOST POPULAR

News

Articles

Blogs